Assetmark, Inc Taro Pharmaceutical Industries LTD Transaction History

Assetmark, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$54.41 - $68.2 $272 - $341	-5 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$59.35 - $88.73 $296 - $443	-5 Reduced 50.0%	5 $0
Q3 2019 Nov 13, 2019	BUY	$75.36 - $86.57 $226 - $259	3 Added 42.86%	10 $1,000
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $83 - $108	1 Added 16.67%	7 $1,000
Q4 2018 Feb 13, 2019	SELL	$78.25 - $107.92 $469 - $647	-6 Reduced 50.0%	6 $1,000
Q2 2018 Aug 01, 2018	SELL	$97.62 - $120.59 $97 - $120	-1 Reduced 7.69%	12 $1,000
Q1 2018 May 16, 2018	SELL	$95.91 - $107.26 $575 - $643	-6 Reduced 31.58%	13 $1,000
Q4 2017 Feb 13, 2018	BUY	$104.5 - $126.38 $731 - $884	7 Added 58.33%	19 $2,000
Q3 2017 Nov 08, 2017	BUY	$97.26 - $116.2 $1,167 - $1,394	12	12 $1,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.